Wegovy maker sues Hims & Hers
Digest more
Hims & Hers is rolling out a compounded semaglutide pill at a fraction of the price of Wegovy.
Amid the fast-moving rollout of the Wegovy pill, Novo Nordisk has taken to advertising’s biggest stage to help get the word out. | Amid the fast-moving rollout of the Wegovy pill, Novo Nordisk has taken to advertising’s biggest stage to help get the word out.
Hims & Hers says it will stop selling a low-cost copy of a new weight-loss pill made by Novo Nordisk, after federal officials raised concerns that the product may violate drug laws.
There's another fight brewing around GLP-1 drugs -- this time on the delivery side.
Hims & Hers stock tumbled in early action on Monday after the U.S. company quickly reversed plans to introduce its own version of Novo Nordisk’s Wegovy oral weight-loss drug.
The FDA requested that Novo take immediate action to address the violations, which could include ceasing all ads containing misleading claims about the pill.